.svg)
The successful recovery of 17-year-old Ahmed Khan marks a global benchmark in the management of ultra-rare genetic coagulopathies during high-stakes neurosurgery.
The recent discharge of Ahmed Khan from Sheffield Children’s Hospital following a complex 13-hour cranial procedure signifies more than a routine surgical success; it is a testament to a world-first multidisciplinary strategy. Ahmed, a British Pakistani student currently studying for his T-levels in mechanical engineering, was diagnosed as an infant with Bernard-Soulier syndrome, an inherited condition affecting fewer than 100 people in the UK. The disorder prevents platelets from clotting effectively, turning even minor injuries into life-threatening events. When Ahmed developed a pineal brain tumour in 2023, characterized by double vision and rapid growth that failed to respond to chemotherapy, the clinical team was forced to navigate a "no-win" scenario where the surgery required to save his life was nearly impossible to perform due to his blood’s inability to clot.
The operation's success hinged on an unprecedented logistical feat involving 113 individual donors. Because Ahmed had developed specific antibodies from previous transfusions, standard blood products would have been rejected by his immune system. In a meticulous collaboration with NHS Blood and Transplant, surgeons secured 113 units of highly specialized, tissue-matched platelets—10 for the procedure itself and 24 for the immediate recovery phase. This "precision matching" allowed Consultant Neurosurgeon Mr Veejay Bagga to resect the tumour from the pineal gland, a high-risk area of the brain, without the patient succumbing to catastrophic intraoperative haemorrhage.
Ahmed told journalists that he would not be here today without the skill and dedication of the surgeons and the team at Sheffield Children’s, noting they gave him a chance to continue his life and look forward to the future. His mother, Maryam Bilal—a professional nurse who recognized the gravity of the diagnosis early on—told journalists that the team gave Ahmed a chance they never thought was possible, adding that their expertise, care, and planning made all the difference.
Looking ahead, Ahmed has already returned to his studies and has remarkably taken up running, a feat once thought impossible. The data gathered from this 13-hour operation is expected to reshape how the NHS manages "inoperable" tumours in patients with severe bleeding disorders. By proving that a combination of advanced HLA-matching and surgical precision can overcome the lethal risks of Bernard-Soulier syndrome, the Sheffield team has effectively rewritten the protocol for rare-disease oncology.
Mr Bagga told journalists that if they had done nothing, the tumour would have been fatal, and while the surgery carried enormous risks, it was the only option. Dr Jeanette Payne, the Consultant Haematologist who has cared for Ahmed since birth, told journalists that treating cancer in someone with a severe bleeding disorder is incredibly challenging, but the outcome has been brilliant.
